Juvelook is PDLLA — poly-D,L-lactic acid — combined with hyaluronic acid. People search Juvelook PLLA, but PLLA is poly-L-lactic acid and the basis of Sculptra; Juvelook is neither that nor polydioxanone.
One letter separates the two polymers, and that letter changes how the material is made, handled and injected.
Search Juvelook PLLA and you will find pages that flatly call it a PLLA product. Some are careless, some are translating loosely, and the effect is the same: a reader trying to compare two stimulators on ingredient grounds cannot get a straight answer.
This guide gives the chemistry plainly, then explains why the distinction is worth anything at all to a patient rather than a chemist.
For context on who is answering: Relieve Clinic is in Apgujeong, Seoul, where Dr. Park Tae-oh has practised for over fifteen years across more than 30,000 clinical cases.
The consultation and the injection are done by the same doctor, and sealed product cartons are opened in front of the patient so the brand and expiry can be read before anything is drawn up.
The short answer: Juvelook is PDLLA, and the letter matters
Lactic acid exists in two mirror-image forms, labelled L and D. A polymer built only from the L form is PLLA. A polymer built from both forms mixed together is PDLLA.
Chemically they are close relatives; physically they are not interchangeable.
Juvelook, produced by the Korean manufacturer VAIM, is the PDLLA one, and it arrives with hyaluronic acid in the same syringe.
Sculptra is the long-standing PLLA reference in this market and is a reasonable comparison point, but it is a different material with its own handling conventions — anyone who tells you the two behave identically because both end in lactic acid is skipping the interesting part.
What PLLA and PDLLA actually differ in
Uniform building blocks stack neatly. Mixed ones do not. That is the whole of it, translated into polymer terms: a chain made purely of L units can pack into ordered crystalline regions, while a chain built from a mix of D and L units is disordered and stays essentially amorphous.
Order and disorder change how a particle sits in tissue, how water reaches it, and how evenly the body works through it.
We are not going to quote you a crystallinity percentage or a degradation half-life, because the published figures vary with the specific manufacturing process and repeating one as though it were a property of the category would be misleading.
Both polymers eventually break down into lactic acid, a compound the body already handles routinely — PubChem’s entry for lactic acid is the reference if you want the underlying chemistry.
| Property | PLLA | PDLLA |
| Full name | Poly-L-lactic acid | Poly-D,L-lactic acid |
| Building blocks | L-lactic acid units only | Both D and L units |
| Chain arrangement | Can form ordered crystalline regions | Disordered, essentially amorphous |
| Market reference product | Sculptra | Juvelook |
| Paired carrier | Reconstituted before use | Supplied with hyaluronic acid |
| Breakdown endpoint | Lactic acid | Lactic acid |
One caution about reading that table: the two columns describe materials, not verdicts. Neither polymer is the superior one in the abstract.
They are handled differently, they suit different plans, and a doctor choosing between them is choosing a protocol rather than declaring a winner. The carrier row, though, is the one patients actually feel, so it gets its own section.
Why Juvelook is paired with hyaluronic acid
Hyaluronic acid in a PDLLA syringe is doing two jobs. It suspends the microspheres so they can be distributed evenly rather than clumping, and it holds water, which is why there is a soft, hydrated-looking change in the first days that has nothing to do with collagen yet.
Understanding that split saves a lot of anxiety. The early change is the carrier. The later change is your own tissue responding to the polymer.
When patients message us at the two-week mark convinced something has worn off, what has usually happened is exactly what should happen: the HA component has settled and the slower process has not yet become visible.
💡 Choosing between the two products as a treatment decision rather than a chemistry question? Juvelook vs Sculptra takes over where this one stops.
What PDLLA changes about onset and duration
Every collagen stimulator shares the same basic shape of timeline: little on day one, the real change accruing across months, then a gradual decline rather than an expiry date. PDLLA does not escape that pattern, and any page promising otherwise is selling something.
- Days 0 to 3: mild swelling and the hydrating effect of the hyaluronic acid carrier. Pinpoint marks settle quickly.
- Weeks 1 to 2: the carrier effect recedes. This is the point where people wrongly conclude nothing worked.
- Weeks 4 to 8: texture change typically becomes noticeable if the course is on track.
- Around month 3: the remodelling response is generally at its most active, which is when we review against the first 3D skin scan.
- Beyond: a gradual fade, with duration varying by individual, age and how many sessions were completed.
Course design follows the same logic. Sessions are spaced weeks apart so one response can mature before the next stimulus is added — stacking them closer does not speed anything up, it just removes your ability to tell which session did what.
Does PDLLA change safety or nodule risk
Nodule formation is a recognised consideration across the entire injectable stimulator class, not a quirk of one polymer, and it is discussed openly before any consent is signed.
Side effects in this category are uncommon and are explained beforehand rather than glossed over, which is the only sensible way to have the conversation with someone who will be back on a plane within the week.
What reduces the risk is mostly technique rather than chemistry: appropriate depth for the region being treated, even distribution instead of concentrated deposits, correct dilution and handling, and aftercare instructions that the patient actually follows.
Thin skin over the temple or the jawline is treated differently from the mid-cheek.
This is also where booking pace matters — we schedule two to three patients an hour rather than running a conveyor, because unhurried injection is the condition under which even distribution is possible.
Products used in Korea are registered with the Ministry of Food and Drug Safety, and the MFDS English portal lets an international patient confirm that what they have been offered is approved for use here.
What to ask before you book a Juvelook PLLA or PDLLA session
A short list of questions will tell you more about a clinic than any brochure. Ask which polymer the product actually is and let the answer show you whether the person in front of you knows.
Ask whether the doctor consulting is the doctor injecting. Ask how long the numbing is left on, because thirty to fifty minutes and ten minutes are not the same appointment. Ask how progress will be assessed at the review, and whether a measurement is taken rather than an impression recorded.
Background reading helps too. Our overview of what the Juvelook skin booster is covers the treatment end to end, the category question is answered in is Juvelook a filler, and how sessions are quoted is set out in our guide to collagen stimulator cost in Korea.
One planning note for visitors: since 1 January 2026 the VAT refund on cosmetic treatment for foreign patients has been discontinued, so the quoted amount plus ten percent VAT is the final out-of-pocket figure and there is nothing to reclaim on departure.
Nothing here is a diagnosis or a treatment recommendation. Individual results vary, and whether PDLLA suits your skin is a judgement made in person by a licensed doctor after examining it.
Schedule Your Free Consultation with Our Doctor
Is Juvelook PLLA or PDLLA?
PDLLA, meaning poly-D,L-lactic acid, supplied together with hyaluronic acid. PLLA is poly-L-lactic acid, the polymer used in Sculptra. Pages describing Juvelook as PLLA have the letter wrong.
Does Juvelook contain polydioxanone?
No. Polydioxanone is the material used in thread lifting and is a different polymer altogether. Juvelook is a PDLLA microsphere product carried in hyaluronic acid.
Why does the D and L distinction matter to a patient?
It affects how the polymer is arranged and handled, which in turn shapes how a doctor dilutes, places and spaces the treatment. For the patient it mostly shows up as a difference in protocol rather than a difference you can see in a mirror on day one.
Dr. Park Tae-oh is the founder and director of Relieve Clinic Seoul in Apgujeong, Gangnam, where he performs consultation and treatment personally. His work centers on reducing discomfort during aesthetic dermatology, drawing on more than 30,000 clinical cases. In June 2026 he demonstrated periorbital radiofrequency technique using XERF at Cynosure Lutronic Academy Korea.
🎁 First-time visitor? Get FREE Recovery Care (₩100,000 value)
Fill Out the Form Now→